DESENEX MEDICATED SPRAY-ON POWDER 20 %
ZINC UNDECYLENATE : 20 % UNDECYLENIC ACID : 2 % · DIN 02021900 · NOVARTIS CONSUMER HEALTH CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is DESENEX MEDICATED SPRAY-ON POWDER?
DESENEX MEDICATED SPRAY-ON POWDER 20 % contains ZINC UNDECYLENATE : 20 % UNDECYLENIC ACID : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02021900, held by NOVARTIS CONSUMER HEALTH CANADA INC., supplied as AEROSOL ; POWDER for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02021900 |
|---|---|
| Brand name | DESENEX MEDICATED SPRAY-ON POWDER |
| Generic / active ingredient | ZINC UNDECYLENATE : 20 % UNDECYLENIC ACID : 2 % |
| Manufacturer | NOVARTIS CONSUMER HEALTH CANADA INC. |
| Strength | 20 % |
| Dosage form | AEROSOL ; POWDER |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AE04 UNDECYLENIC ACID |
| AHFS class | 84:04.08.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 21-Jul-1999 |
| Original market date | 1994-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02021900 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2021900 |
| Brand name | DESENEX MEDICATED SPRAY-ON POWDER |
| Active ingredient / INN | ZINC UNDECYLENATE : 20 % UNDECYLENIC ACID : 2 % |
| ATC code | D01AE04 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D01 |
| AHFS class | 84:04.08.92 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | NOVARTIS CONSUMER HEALTH CANADA INC. |
Which pack is which?
| Strength on the label | 20 % |
|---|---|
| Dosage form | AEROSOL ; POWDER |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code D01AE04 UNDECYLENIC ACID. 0 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CRUEX ANTIFUNGAL CREAM | 3 % | CREAM | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021838 |
| CRUEX MEDICATED PWR 10% | 10 % | POWDER | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021854 |
| CRUEX MEDICATED SPRAY POWDER | 2 % | POWDER ; AEROSOL | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021846 |
| DESENEX ANTIFUNGAL POWDER | 20 % | POWDER | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021862 |
| FOOT AND BODY POWDER | 908 G / 91.7 Kg | POWDER | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240605 |
| FOOT SPRAY WITH POWDER | .35 % | AEROSOL | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240656 |
| FUNGAL FOOT SPRAY 0.1% | .1 % | AEROSOL | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240664 |
| FUNGI-RID - LIQ 10% | 10 % | LIQUID | TRIPOD FAMILY FOOT CARE CENTRES INC. | CANCELLED POST MARKET | DIN 02222736 |
| ZINC UNDECYLENATE | 2 % | POWDER | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00595926 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.